断颈交感神经干大鼠DO中牵张区NE/adrb3的表达与MSCs动员的关系

摘要/Abstract

摘要： 目的检测断颈交感神经干后牵张成骨（distraction osteogenesis,DO）牵张区去甲肾上腺素（NE）/β3肾上腺素能受体（adrb3）及间充质干细胞标志物Nestin的表达情况,并分析其间的相关性。方法 SD成年雄性大鼠20只,平均分为4组（n=5）。实验组行右侧下颌骨牵张器植入术复合颈交感神经干离断术,对照组行右侧下颌骨牵张器植入术,分别于牵张期开始和牵张期结束处死动物并取材,免疫组织化学检测各组NE/adrb3的表达。应用SPSS13.0软件包对数据进行组间t检验。结果 NE/adrb3主要表达于血管周。与对照组相比,断交感神经后NE/adrb3随着时间延长,表达逐渐减弱,到牵张期结束已无明显表达;实验组Nestin在牵张期开始及结束时,均广泛表达于成骨基质和血管周,且主要集中于成骨基质,而对照组Nestin主要表达于血管周。结论牵张成骨（DO）中交感神经通过NE/adrb3反向调控间充质干细胞（MSCs）动员及向成骨基质迁移。

关键词: 牵张成骨, 颈交感神经干离断术, 去甲肾上腺素, β, 3肾上腺素能受体, 间充质干细胞

Abstract: PURPOSE: To determine the alternation of NE/adrb3, Nestin expression in rat model after sympathetic deneration during distraction osteogenesis. METHODS: According to different intervention and time point, 20 adult male SD rats were divided into 4 groups (n=5) equally. Rats in the experimental group underwent right mandible distraction osteogenesis and transection of cervical sympathetic trunk (TCST), while rats in the control group only underwent right mandible distraction osteogenesis. The right mandibles and the distraction zone specimens were harvested for immunohistochemistry assays of NE/ adrb3 expression and mesenchymal stem cells (MSCs) distribution at specific time point. The data were analyzed using SPSS 13.0 software package. RESULTS: The expression of NE was hardly found, and very weak adrb3 expression was observed around the blood vessel in TCST group, but the expression of NE and adrb3 was abundant in the control group; the Nestin+ MSCs were abundant and mainly distributed in callus matrix in TCST group, whereas that Nestin+ MSCs were mainly located adjacent to perivascular region in the control group. CONCLUSIONS: TCST depleted sympathetic mediator NE and its receptor adrb3 in distraction zone; Nestin+ MSCs have higher tendency of migration from perivascular region to callus matrix under distraction stress after TCST in vivo.

Key words: Distraction osteogenesis, Transection of cervical sympathetic trunk, Norepinephrine, Beta 3 adrenergic receptor, Mesenchymal stem cells

中图分类号:

杜兆杰, 张雅博, 符涛, 石东岳, 杨擎天. 断颈交感神经干大鼠DO中牵张区NE/adrb3的表达与MSCs动员的关系[J]. 中国口腔颌面外科杂志, 2016, 14(6): 505-509.

DU Zhao-jie, ZHANG Ya-bo, FU Tao, SHI Dong-yue, YANG Qing-tian. Effect of sympathetic denervation on alternation of NE/adrb3 expression and MSCs distribution in rat distraction osteogenesis model[J]. China J Oral Maxillofac Surg, 2016, 14(6): 505-509.

参考文献

[1] Wang T, Cao J, Du ZJ, et al. Effects of sympathetic innervation loss on mandibular distraction osteogenesis [J]. J Craniofac Surg, 2012, 23(5): 1524-1528.
[2] Minkowitz B, Boskey AL, Lane JM, et al. Effects of propranolol on bone metabolism in the rat [J]. J Orthop Res, 1991, 9(6): 869-875.
[3] Sseur R, Sabatier JP, Potrel-Burgot C, et al. Sympathetic nervous system as transmitter of mechanical loading in bone [J]. Joint Bone Spine, 2003, 70(6): 515-519.
[4] Ke HZ, Xu G, Brault AL. Deletion of the b2 adrenergic receptor prevents bone loss induced by isoproterenol in mice [J]. J Bone Miner Res, 2004, 19(Suppl): S3.
[5] Dhillon H, Glatt V, Ferrari SL, et al. β-adrenergic receptor KO mice have increased bone mass and strength but are not protected from ovariec-tomy-induced bone loss [J]. J Bone Miner Res, 2004, 19(Suppl): S32.
[6] Okada Y, Hamada N, Kim Y, et al. Blockade of sympathetic beta-receptors inhibits Porphyromonas gingivalis - induced alveolar bone loss in an experimental rat periodontitis model [J]. Arch Oral Biol, 2010, 55(7): 502-508.
[7] Cherruau M, Facchinetti P, Baroukh B, et al. Chemical sympathectomy impairs bone resorption in rats: a role for the sympathetic system on bone metabolism[J]. Bone, 1999, 25(5): 545-551.
[8] Ducy P, Amling M, Takeda S, et al. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass [J]. Cell, 2000, 100(2): 197-207.
[9] Takeda S, Elefteriou F, Levasseur R, et al. Leptin regulates bone formation via the sympathetic nervous system[J]. Cell, 2002, 111(3): 305-317.
[10] Takeda S, Karsenty G. Molecular bases of the sympathetic regulation of bone mass [J]. Bone, 2008, 42(5): 837-840.
[11] Rejnmark L, Vestergaard P, Mosekilde L. Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case-control study [J]. J Hypertens, 2006, 24(3): 581-589.
[12] de Vries F1, Souverein PC, Cooper C, et al. Use of beta-blockers and the risk of hip/femur fracture in the United Kingdom and the Netherlands [J]. Calcif Tissue Int, 2007, 80(2): 69-75.
[13] Méndez-Ferrer S, Michurina TV, Ferraro F, et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche[J]. Nature, 2010, 446(7308): 829-834.
[14] Spradling A, Drummond-Barbosa D, Kai T. Stem cells find their niche [J]. Nature, 2001, 414(6859): 98-104.
[15] Shi S, Gronthos S. Perivascular niche of postnatal mesenchymal stem cells in human bone marrow and dental pulp [J]. J Bone Miner Res, 2003, 18(4): 696-704.